Substantial compliance and medicament classification guide exemption treatment and patent-or-proprietary status

Substantial compliance with an exemption notification may suffice where sample packs convey that they are not for sale, so the use of the words "Samples not for sale" did not justify denial of exemption in place of the prescribed wording. For computing the 4% limit for physician's samples, duty-free clearances under the earlier notification were counted, as nil duty was treated as duty paid for this purpose. On classification, medicaments bearing the symbol "M" within a semi-circular device were treated as carrying a trade connection and therefore did not qualify as goods other than patent or proprietary medicaments under sub-heading 3003.20.

---

---

Issues: (i) Whether exemption under Notification No. 48/77 could be denied because the sample packs bore the words "Samples not for sale" instead of "Physician's samples not to be sold", and whether duty-free clearances under Notification No. 175/86 were to be included while computing the 4% limit for physician's samples; (ii) Whether medicaments bearing the symbol "M" enclosed within a semi-circular device were classifiable as medicaments other than patent or proprietary medicaments under sub-heading 3003.20.

Issue (i): Whether exemption under Notification No. 48/77 could be denied because the sample packs bore the words "Samples not for sale" instead of "Physician's samples not to be sold", and whether duty-free clearances under Notification No. 175/86 were to be included while computing the 4% limit for physician's samples.

Analysis: The condition in Notification No. 48/77 was meant to ensure that the packs were clearly identifiable as physician's samples and not meant for sale. The wording used on the packs conveyed the same effect as the prescribed expression, and the requirement was therefore substantially satisfied. For computing the 4% value limit, clearances made under full exemption were relevant because nil duty payment is still payment of duty for the purpose of the notification.

Conclusion: Exemption under Notification No. 48/77 could not be denied on the ground of the altered wording on the sample packs, and duty-free clearances under Notification No. 175/86 had to be taken into account while computing the 4% limit. This issue was decided in favour of the assessee.

Issue (ii): Whether medicaments bearing the symbol "M" enclosed within a semi-circular device were classifiable as medicaments other than patent or proprietary medicaments under sub-heading 3003.20.

Analysis: A medicament bearing a symbol or mark used in relation to the medicine may indicate a trade connection and attract the description of patent or proprietary medicaments. Since the symbol appeared on the packets and was used on the goods, the medicaments ceased to answer the description of goods other than patent or proprietary medicaments.

Conclusion: The medicaments were not classifiable under sub-heading 3003.20 and the Revenue succeeded on this issue.

Final Conclusion: The exemption dispute was resolved in favour of the assessee, while the classification dispute was resolved in favour of the Revenue, resulting in a mixed outcome with the assessee obtaining substantive relief on one issue and the Revenue succeeding on the other.

Ratio Decidendi: For exemption notifications, substantial compliance with the prescribed marking may suffice where the essential object of the condition is met; and a symbol used on medicaments to indicate trade connection may render them patent or proprietary medicaments for classification purposes.

---